Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition) Yoshiki NishizawaHiroaki OhtaNoriko Yoshimura Special Report 10 November 2012 Pages: 1 - 15
Assessment of safety and efficacy of methylsulfonylmethane on bone and knee joints in osteoarthritis animal model Junko EzakiMiyuki HashimotoYoshiko Ishimi Original article 10 August 2012 Pages: 16 - 25
Clinically applicable antianginal agents suppress osteoblastic transformation of myogenic cells and heterotopic ossifications in mice Ryuichiro YamamotoMasaki MatsushitaKinji Ohno Original article 24 August 2012 Pages: 26 - 33
Identification of a novel bone morphogenetic protein (BMP)-inducible transcript, BMP-inducible transcript-1, by utilizing the conserved BMP-responsive elements in the Id genes Masashi ShinSatoshi OhteTakenobu Katagiri Original article 14 September 2012 Pages: 34 - 43
Peroxisome proliferator-activated receptor delta agonist attenuates nicotine suppression effect on human mesenchymal stem cell-derived osteogenesis and involves increased expression of heme oxygenase-1 Dong Hyun KimJiayong LiuBruce E. Heck Original article 05 September 2012 Pages: 44 - 52
Retinoic acid regulates commitment of undifferentiated mesenchymal stem cells into osteoblasts and adipocytes Kunihiro HisadaKenji HataToshiyuki Yoneda Original article 27 September 2012 Pages: 53 - 63
Adenosine blocks aminopterin-induced suppression of osteoclast differentiation Junpei TeramachiAkiko KukitaToshio Kukita Original Article 01 November 2012 Pages: 64 - 70
High bone mass in the STR/ort mouse results from increased bone formation and impaired bone resorption and is associated with extramedullary hematopoiesis Juliane PasoldRobby EngelmannBrigitte Müller-Hilke Original Article 29 November 2012 Pages: 71 - 81
Bone texture analysis is correlated with three-dimensional microarchitecture and mechanical properties of trabecular bone in osteoporotic femurs Thomas Le CorrollerMartine PithiouxPatrick Chabrand Original article 11 August 2012 Pages: 82 - 88
Effects of raloxifene on lipid and bone metabolism in postmenopausal women with type 2 diabetes Hiroko MoriYosuke OkadaYoshiya Tanaka Original article 07 August 2012 Pages: 89 - 95
Association between estrogen receptor-β dinucleotide repeat polymorphism and incidence of femoral fracture Naoko HonmaSeijiro MoriHideki Ito Original Article 05 September 2012 Pages: 96 - 101
Fracture risk is increased by the complication of hypertension and treatment with calcium channel blockers in postmenopausal women with type 2 diabetes Shin TakaokaToru YamaguchiToshitsugu Sugimoto Original article 17 October 2012 Pages: 102 - 107
Vitamin D receptor gene polymorphisms and bone mass indices in post-menarchal Indian adolescent girls Neha SanwalkaAnuradha KhadilkarVaman Khadilkar Original article 19 October 2012 Pages: 108 - 115
Oral alendronate can suppress bone turnover but not fracture in kidney transplantation recipients with hyperparathyroidism and chronic kidney disease Sakura YamamotoAtsushi SuzukiMitsuyasu Itoh Original article 18 October 2012 Pages: 116 - 122
A case of multiple brown tumors with primary hyperparathyroidism Hiroko MoriYosuke OkadaYoshiya Tanaka Case report 20 June 2012 Pages: 123 - 127